Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [14]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20000-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#20000-1-AP, RRID:AB_10664930
- Product name
- TGFBR3-Specific antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TGFBR3-Specific antibody (Cat. #20000-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Spatial patterning of fibroblast TGFβ signaling underlies treatment resistance in rheumatoid arthritis.
Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis.
Spatial patterning of fibroblast TGFβ signaling underlies treatment resistance in rheumatoid arthritis.
ADP-ribosylation of NuMA promotes DNA single-strand break repair and transcription.
The development of pyridazinone-based andrographolide derivatives as anti-cancer agents with the ability of inhibiting the TFAP4/Wnt/β-catenin signaling pathway.
De novo designed protein guiding targeted protein degradation.
WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRAS(G12C)-mutant lung cancer.
FAM122A functions as a tumor suppressor in oral squamous cell carcinoma.
Spatially multicellular variability of intervertebral disc degeneration by comparative single-cell analysis.
CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression.
FoxO1 regulates adipose transdifferentiation and iron influx by mediating Tgfβ1 signaling pathway.
The miR-103a-3p/TGFBR3 axis regulates TGF-β-induced orbital fibroblast activation and fibrosis in thyroid-eye disease.
Vitamin D3 alleviates pulmonary fibrosis by regulating the MAPK pathway via targeting PSAT1 expression in vivo and in vitro.
Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Bhamidipati K, McIntyre ABR, Kazerounian S, Ce G, Wong SW, Tran M, Prell SA, Lau R, Khedgikar V, Altmann C, Small A, Madhu R, Presti SR, Anufrieva KS, Blazar PE, Lange JK, Seifert JA, Accelerating Medicines Partnership RA/SLE Network, Accelerating Medicines Partnership: Autoimmune and Immune-Mediated Diseases Network (AMP-AIM), Colorado Interdisciplinary Joint Biology Program (CUIJBP) Consortium, Moreland LW, Croft AP, Smith MH, Donlin LT, Lewis MJ, Jonsson AH, Pitzalis C, Thomas R, Gravallese EM, Brenner MB, Korsunsky I, Wechalekar MD, Wei K
Nature immunology 2026 Mar;27(3):556-571
Nature immunology 2026 Mar;27(3):556-571
Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis.
Kocot J, Kosa P, Ashida S, Pirjanian NA, Goldbach-Mansky R, Peterson K, Fossati V, Holland SM, Bielekova B
The Journal of clinical investigation 2025 May 15;135(10)
The Journal of clinical investigation 2025 May 15;135(10)
Spatial patterning of fibroblast TGFβ signaling underlies treatment resistance in rheumatoid arthritis.
Bhamidipati K, McIntyre ABR, Kazerounian S, Ce G, Tran M, Prell SA, Lau R, Khedgikar V, Altmann C, Small A, Wong V, Madhu R, Presti S, Anufrieva KS, Blazar PE, Lange JK, Seifert J, Accelerating Medicines Partnership: RA/SLE Network, Accelerating Medicines Partnership: Autoimmune and Immune-Mediated Diseases Network (AMP-AIM), Moreland LW, Croft AP, Lewis MJ, Thomas R, Jonsson AH, Pitzalis C, Gravallese EM, Brenner MB, Korsunsky I, Wechalekar MD, Wei K
bioRxiv : the preprint server for biology 2025 Mar 17;
bioRxiv : the preprint server for biology 2025 Mar 17;
ADP-ribosylation of NuMA promotes DNA single-strand break repair and transcription.
Abugable AA, Liao C, Antar S, Dowson M, El-Khamisy SF
Cell reports 2025 Jun 24;44(6):115737
Cell reports 2025 Jun 24;44(6):115737
The development of pyridazinone-based andrographolide derivatives as anti-cancer agents with the ability of inhibiting the TFAP4/Wnt/β-catenin signaling pathway.
Zhang H, Xu Z, Xu Z, Bian S, Qiao N, Wang X, Zhang M, Guo F, Cui Y, Zheng F, Liu J, Wu D, Xu H
Bioorganic chemistry 2025 Jun 15;160:108440
Bioorganic chemistry 2025 Jun 15;160:108440
De novo designed protein guiding targeted protein degradation.
Li Z, Qiao G, Wang X, Wang M, Cheng J, Hu G, Li X, Wu J, Liu J, Gao C, Liu L
Nature communications 2025 Jul 17;16(1):6598
Nature communications 2025 Jul 17;16(1):6598
WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRAS(G12C)-mutant lung cancer.
Zhou C, Liu Y, Liu H, Lu J, Zhang B, Zhu L, Wang S, Lei H, Han B
Cell death & disease 2025 Aug 30;16(1):661
Cell death & disease 2025 Aug 30;16(1):661
FAM122A functions as a tumor suppressor in oral squamous cell carcinoma.
Zhu H, Huang Y, Chen J
Experimental cell research 2024 Aug 15;441(2):114165
Experimental cell research 2024 Aug 15;441(2):114165
Spatially multicellular variability of intervertebral disc degeneration by comparative single-cell analysis.
Lin P, Yan P, Zhu J, Huang S, Wang Z, Hu O, Jin H, Li Y, Zhang L, Zhao J, Chen L, Liu B, He J, Gan Y, Liu P
Cell proliferation 2023 Oct;56(10):e13464
Cell proliferation 2023 Oct;56(10):e13464
CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression.
Gong Q, Wang Y, Zhu K, Bai X, Feng T, Sun G, Wang M, Pan X, Qin C
Biochemical and biophysical research communications 2023 Oct 8;676:58-65
Biochemical and biophysical research communications 2023 Oct 8;676:58-65
FoxO1 regulates adipose transdifferentiation and iron influx by mediating Tgfβ1 signaling pathway.
Shi L, Tao Z, Zheng L, Yang J, Hu X, Scott K, de Kloet A, Krause E, Collins JF, Cheng Z
Redox biology 2023 Jul;63:102727
Redox biology 2023 Jul;63:102727
The miR-103a-3p/TGFBR3 axis regulates TGF-β-induced orbital fibroblast activation and fibrosis in thyroid-eye disease.
Xie B, Xiong W, Zhang F, Wang N, Luo Y, Chen Y, Cao J, Chen Z, Ma C, Chen H
Molecular and cellular endocrinology 2023 Jan 1;559:111780
Molecular and cellular endocrinology 2023 Jan 1;559:111780
Vitamin D3 alleviates pulmonary fibrosis by regulating the MAPK pathway via targeting PSAT1 expression in vivo and in vitro.
Zhu W, Ding Q, Wang L, Xu G, Diao Y, Qu S, Chen S, Shi Y
International immunopharmacology 2021 Dec;101(Pt B):108212
International immunopharmacology 2021 Dec;101(Pt B):108212
Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY, Yu G, Lee YC, Lin SC, Pan J, Pan T, Yu KJ, Liu B, Creighton CJ, Rodriguez-Canales J, Villalobos PA, Wistuba II, de Nadal E, Posas F, Gallick GE, Lin SH
Cancer research 2018 Jun 1;78(11):2911-2924
Cancer research 2018 Jun 1;78(11):2911-2924
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TGFBR3-Specific antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human TGFBR3-Specific. This antibody recognizes human antigen. The TGFBR3-Specific antibody has been validated for the following applications: ELISA, WB analysis.
